These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10577608)

  • 1. Akinetopsia from nefazodone toxicity.
    Horton JC; Trobe JD
    Am J Ophthalmol; 1999 Oct; 128(4):530-1. PubMed ID: 10577608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nefazodone overdose: a case report.
    Catalano G; Catalano MC; Tumarkin NB
    Clin Neuropharmacol; 1999; 22(1):63-5. PubMed ID: 10047937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    Sussman N; Ginsberg DL; Bikoff J
    J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel serotonergic mechanisms and clinical experience with nefazodone.
    Fontaine R
    Clin Neuropharmacol; 1993; 16 Suppl 3():S45-50. PubMed ID: 8131154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual "trails" with nefazodone treatment.
    Kraus RP
    Am J Psychiatry; 1996 Oct; 153(10):1365-6. PubMed ID: 8831452
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotonin syndrome associated with nefazodone and paroxetine.
    John L; Perreault MM; Tao T; Blew PG
    Ann Emerg Med; 1997 Feb; 29(2):287-9. PubMed ID: 9018197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of antidepressants: focus on nefazodone.
    DeVane CL; Grothe DR; Smith SL
    J Clin Psychiatry; 2002; 63 Suppl 1():10-7. PubMed ID: 11890560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nefazodone poisoning: toxicokinetics and toxicodynamics using continuous data collection.
    Isbister GK; Hackett LP
    J Toxicol Clin Toxicol; 2003; 41(2):167-73. PubMed ID: 12733855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nefazodone: a new antidepressant.
    Ellingrod VL; Perry PJ
    Am J Health Syst Pharm; 1995 Dec; 52(24):2799-812. PubMed ID: 8748566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and safety: essentials in antidepressant pharmacotherapy.
    Lader MH
    J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and peripheral vision loss associated with nefazodone usage.
    Luu C; Kiely P; Crewther D; Kowal L; Crewther S
    Doc Ophthalmol; 2003 May; 106(3):319-25. PubMed ID: 12737510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    Elliott AJ; Russo J; Bergam K; Claypoole K; Uldall KK; Roy-Byrne PP
    J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
    Rush AJ; Armitage R; Gillin JC; Yonkers KA; Winokur A; Moldofsky H; Vogel GW; Kaplita SB; Fleming JB; Montplaisir J; Erman MK; Albala BJ; McQuade RD
    Biol Psychiatry; 1998 Jul; 44(1):3-14. PubMed ID: 9646878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study.
    Coleman E; Gratzer T; Nesvacil L; Raymond NC
    J Clin Psychiatry; 2000 Apr; 61(4):282-4. PubMed ID: 10830149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin.
    Narayan M; Anderson G; Cellar J; Mallison RT; Price LH; Nelson JC
    J Clin Psychopharmacol; 1998 Feb; 18(1):67-71. PubMed ID: 9472845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic effects of nefazodone.
    Peak DA
    Ann Emerg Med; 1997 Oct; 30(4):551. PubMed ID: 9326874
    [No Abstract]   [Full Text] [Related]  

  • 17. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
    J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
    Owens MJ; Ieni JR; Knight DL; Winders K; Nemeroff CB
    Life Sci; 1995; 57(24):PL373-80. PubMed ID: 7475971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
    Armitage R; Yonkers K; Cole D; Rush AJ
    J Clin Psychopharmacol; 1997 Jun; 17(3):161-8. PubMed ID: 9169959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of cancer chemotherapy-induced emesis during antidepressant therapy with nefazodone.
    Khouzam HR; Monteiro AJ; Gerken ME
    Psychosom Med; 1998; 60(1):89-91. PubMed ID: 9492245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.